The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 45,277,024 | 2,405,793 | SH | SOLE | 2,405,793 | 0 | 0 | ||
ALDEYRA THERAPEUTICS INC | COM | 01438T106 | 1,596,744 | 160,800 | SH | SOLE | 160,800 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 24,928,515 | 74,605 | SH | SOLE | 74,605 | 0 | 0 | ||
ALKERMES PLC | COM | G01767105 | 17,009,846 | 603,400 | SH | SOLE | 603,400 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 116,711,404 | 10,524,022 | SH | SOLE | 10,524,022 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 9,383,434 | 431,224 | SH | SOLE | 431,224 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 106,007,834 | 381,282 | SH | SOLE | 381,282 | 0 | 0 | ||
BIOMARIN PHARMACEUTICAL INC | COM | 09061G101 | 178,049,843 | 1,831,035 | SH | SOLE | 1,831,035 | 0 | 0 | ||
CYTOKINETICS INC | COM | 23282W605 | 3,931,321 | 111,717 | SH | SOLE | 111,717 | 0 | 0 | ||
EHEALTH INC | COM | 28238P109 | 25,172,587 | 2,689,379 | SH | SOLE | 2,689,379 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | 4,366,092 | 3,465,152 | SH | SOLE | 3,465,152 | 0 | 0 | ||
GRITSTONE ONCOLOGY INC | COM | 39868T105 | 1,851,833 | 666,127 | SH | SOLE | 666,127 | 0 | 0 | ||
INSMED INC | COM | 457669307 | 100,415,822 | 5,889,491 | SH | SOLE | 5,889,491 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 22,079,158 | 5,675,876 | SH | SOLE | 5,675,876 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 2,053,906 | 656,200 | SH | SOLE | 656,200 | 0 | 0 | ||
MIRUM PHARMACEUTICALS INC | COM | 604749101 | 1,554,094 | 64,700 | SH | SOLE | 64,700 | 0 | 0 | ||
NOVOCURE LTD | COM | G6674U108 | 1,971,991 | 32,790 | SH | SOLE | 32,790 | 0 | 0 | ||
PEAK BIO INC | COM | 70470P108 | 314,141 | 497,528 | SH | SOLE | 497,528 | 0 | 0 | ||
PROTHENA CORP PLC | COM | G72800108 | 80,643,271 | 1,663,777 | SH | SOLE | 1,663,777 | 0 | 0 | ||
PROVENTION BIO INC | COM | 74374N102 | 9,418,280 | 390,800 | SH | SOLE | 390,800 | 0 | 0 | ||
RELMADA THERAPEUTICS INC | COM | 75955J402 | 1,225,146 | 542,100 | SH | SOLE | 542,100 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 169,753,432 | 5,270,209 | SH | SOLE | 5,270,209 | 0 | 0 | ||
SAGE THERAPEUTICS INC | COM | 78667J108 | 36,065,333 | 859,517 | SH | SOLE | 859,517 | 0 | 0 | ||
STAAR SURGICAL CO | COM | 852312305 | 86,161,242 | 1,347,322 | SH | SOLE | 1,347,322 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 12,938,112 | 612,600 | SH | SOLE | 612,600 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY I | COM | 87357P100 | 444,982 | 27,100 | SH | SOLE | 27,100 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 3,734,892 | 166,069 | SH | SOLE | 166,069 | 0 | 0 | ||
UNITED THERAPEUTICS CORP | COM | 91307C102 | 140,538,035 | 627,514 | SH | SOLE | 627,514 | 0 | 0 | ||
UROGEN PHARMA LTD | COM | M96088105 | 226,380 | 24,500 | SH | SOLE | 24,500 | 0 | 0 | ||
VANDA PHARMACEUTICALS INC | COM | 921659108 | 3,277,513 | 482,697 | SH | SOLE | 482,697 | 0 | 0 |